In this study, a series of compounds derived from 4-methoxy-1-isoindole-1,3(2)-dione, potential ligands of phosphodiesterase 10A and serotonin receptors, were investigated as potential antipsychotics. A library of 4-methoxy-1-isoindole-1,3(2)-dione derivatives with various amine moieties was synthesized and examined for their phosphodiesterase 10A (PDE10A)-inhibiting properties and their 5-HT and 5-HT receptor affinities. Based on in vitro studies, the most potent compound, (2-[4-(1-benzimidazol-2-yl)butyl]-4-methoxy-1-isoindole-1,3(2)-dione), was selected and its safety in vitro was evaluated. In order to explain the binding mode of compound in the active site of the PDE10A enzyme and describe the molecular interactions responsible for its inhibition, computer-aided docking studies were performed. The potential antipsychotic properties of compound in a behavioral model of schizophrenia were also investigated.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504677 | PMC |
http://dx.doi.org/10.3390/molecules25173868 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!